Overview

Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the clinical outcomes, safety and efficacy in patients randomized to receive either ketorolac or nepafanac following cataract surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Innovative Medical
Treatments:
Ketorolac
Ketorolac Tromethamine
Nepafenac